Correction (DOI:10.1016/j.jcmg.2009.06.004);Does Coronary Flow Trump Coronary Anatomy?

JACC: Cardiovascular Imaging

Volumn 2, Issue 8, 2009, Pages 1009-1023

  Gould, K Lance ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

CAD; coronary flow; coronary stenosis; quantitative cardiac PET; quantitative myocardial perfusion

Indexed keywords

DIPYRIDAMOLE;

ANATOMICAL VARIATION; ANGIOCARDIOGRAPHY; ARTIFACT REDUCTION; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FRACTIONAL FLOW RESERVE; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION PROCESS;

EID: 68549107828     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.08.001     Document Type: Erratum

References (36)

1. Gould K.L., Lipscomb K., and Hamilton G.W. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33 (1974) 87-94
2. Gould K.L., and Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34 (1974) 48-55
3. Gould K.L. Pressure-flow characteristics of coronary stenoses in unsedated dogs at rest and during coronary vasodilation. Circ Res 43 (1978) 242-253
4. Feldman R.L., Nichols W.W., Pepine C.J., and Conti C.R. Hemodynamic effects of long and multiple coronary arterial narrowings. Chest 74 (1978) 280-285
5. Gould K.L., Kelley K.O., and Bolson E.L. Experimental validation of quantitative coronary arteriography for determining pressure-flow characteristics of coronary stenosis. Circulation 66 (1982) 930-937
6. Gould K.L. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 41 (1978) 267-278
7. Gould K.L., Schelbert H.R., Phelps M.E., and Hoffman E.J. Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation. V. Detection of 47 percent diameter coronary stenosis with intravenous nitrogen-13 ammonia and emission-computed tomography in intact dogs. Am J Cardiol 43 (1979) 200-208
8. Kirkeeide R.L., Gould K.L., and Parsel L. Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VII. Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions. J Am Coll Cardiol 7 (1986) 103-113
9. Gould K.L., Goldstein R.A., Mullani N.A., et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J Am Coll Cardiol 7 (1986) 775-789
10. Gould K.L., Kirkeeide R.L., and Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 15 (1990) 459-474
11. Gould K.L. Coronary Artery Stenosis and Reversing Atherosclerosis. 2nd edition (1999), Arnold Publishers, London
12. White C.W., Wright C.B., Doty D.B., et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?. N Engl J Med 310 (1984) 819-824
13. Meijboom W.B., Van Mieghem C.A., van Pelt N., et al. Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol 52 (2008) 636-643
14. Pijls N.H., van Son J.A., Kirkeeide R.L., De Bruyne B., and Gould K.L. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87 (1993) 1354-1367
15. De Bruyne B., Baudhuin T., Melin J.A., et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 89 (1994) 1013-1022
16. De Bruyne B., Pijls N.H., Heyndrickx G.R., Hodeige D., Kirkeeide R., and Gould K.L. Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation. Circulation 101 (2000) 1840-1847
17. Pijls N.H., van Schaardenburgh P., Manoharan G., et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol 49 (2007) 2105-2111
18. Tonino P.A., De Bruyne B., Pijls N.H., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 (2009) 213-224
19. Koolen J.J., and Pijls N.H. Coronary pressure never lies. Catheter Cardiovasc Interv 72 (2008) 248-256
20. Kern M.J., Lerman A., Bech J.W., et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 114 (2006) 1321-1341
21. Nissen S.E. Limitations of computed tomography coronary angiography. J Am Coll Cardiol 52 (2008) 2145-2147
22. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
23. Lin G.A., Dudley R.A., and Redberg R.F. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med 167 (2007) 1604-1609
24. Lin G.A., Dudley R.A., Lucas F.L., Malenka D.J., Vittinghoff E., and Redberg R.F. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 300 (2008) 1765-1773
25. Yoshida K., Mullani N., and Gould K.L. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 37 (1996) 1701-1712
26. Coxson P.G., Huesman R.H., and Borland L. Consequences of using a simplified kinetic model for dynamic PET data. J Nucl Med 38 (1997) 660-667
27. Loghin C., Sdringola S., and Gould K.L. Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions. J Nucl Med 45 (2004) 1029-1039
28. Gould K.L., Pan T., Loghin C., Johnson N.P., Guha A., and Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections. J Nucl Med 48 (2007) 1112-1121
29. Gould K.L., Pan T., Loghin C., Johnson N.P., and Sdringola S. Reducing radiation dose in rest-stress cardiac PET/CT by single poststress cine CT for attenuation correction: quantitative validation. J Nucl Med 49 (2008) 738-745
30. Johnson N.P., and Gould K.L. Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by Markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects. J Nucl Med 46 (2005) 1427-1437
31. Gould K.L., Nakagawa Y., Nakagawa K., et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography. Circulation 101 (2000) 1931-1939
32. De Bruyne B., Hersbach F., Pijls N.H., et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation 104 (2001) 2401-2406
33. Goldstein R.A., Mullani N.A., Fisher D., Marani S., Gould K.L., and O'Brien H.A. Myocardial perfusion with rubidium-82. II. The effects of metabolic and pharmacologic interventions. J Nucl Med 24 (1983) 907-915
34. Sdringola S., Nakagawa K., Nakagawa Y., et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 41 (2003) 263-272
35. Sdringola S., Loghin C., Boccalandro F., and Gould K.L. Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. J Nucl Med 47 (2006) 59-67
36. Merhige M.E., Breen W.J., Shelton V., Houston T., D'Arcy B.J., and Perna A.F. Impact of myocardial perfusion imaging with PET and 82-Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med 48 (2007) 1069-1076